stoxline Quote Chart Rank Option Currency Glossary
  
National Health Investors, Inc. (NHI)
76.65  0.58 (0.76%)    07-31 16:00
Open: 75.25
High: 76.94
Volume: 383,475
  
Pre. Close: 76.07
Low: 74.74
Market Cap: 3,715(M)
Technical analysis
2026-07-31 4:46:02 PM
Short term     
Mid term     
Targets 6-month :  91.95 1-year :  95.02
Resists First :  78.73 Second :  81.36
Pivot price 78.41
Supports First :  74.47 Second :  61.96
MAs MA(5) :  77.76 MA(20) :  77.88
MA(100) :  77.16 MA(250) :  76.51
MACD MACD :  0.8 Signal :  1.2
%K %D K(14,3) :  34 D(3) :  45.7
RSI RSI(14): 47.9
52-week High :  89.28 Low :  67.13
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ NHI ] has closed above bottom band by 25.0%. Bollinger Bands are 11.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 77.12 - 77.63 77.63 - 78.09
Low: 73.48 - 74.13 74.13 - 74.72
Close: 75.64 - 76.67 76.67 - 77.6
Company Description

Established in 1991, National Health Investors, Inc. (NYSE: NHI) operates as a real estate investment trust (REIT) primarily focused on providing capital for senior living and medical real estate assets. The company facilitates this through diverse financing options, including sale-leaseback arrangements, joint ventures, and various debt instruments such as mortgage and mezzanine loans, targeting properties that cater to both essential care needs and discretionary services. NHI's broad holdings feature independent living, assisted living, and memory care facilities, as well as entrance-fee retirement communities, skilled nursing homes, medical office complexes, and specialized hospitals.

Headline News

Thu, 30 Jul 2026
National Health Investors (NYSE: NHI) awards COO 2,370 restricted shares - Stock Titan

Thu, 30 Jul 2026
National Health Investors (NYSE: NHI) COO submits initial Form 3 - Stock Titan

Wed, 29 Jul 2026
National Health Investors, Inc. (NYSE:NHI) Sees Significant Drop in Short Interest - MarketBeat

Tue, 28 Jul 2026
National Health Investors Appoints First Chief Operating Officer - The Globe and Mail

Mon, 27 Jul 2026
What National Health Investors (NHI)'s New COO Appointment Means For Shareholders - simplywall.st

Mon, 27 Jul 2026
National Health Investors names Chris Maingot as first COO By Investing.com - Investing.com

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Real Estate
Industry:
REIT - Healthcare Facilities
Shares Out 0 (M)
Shares Float 47 (M)
Held by Insiders 2.4 (%)
Held by Institutions 75.7 (%)
Shares Short 2,090 (K)
Shares Short P.Month 1,850 (K)
Stock Financials
EPS 3.09
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 36.5 %
Operating Margin 61.3 %
Return on Assets (ttm) 4.4 %
Return on Equity (ttm) 9.8 %
Qtrly Rev. Growth -2.6 %
Gross Profit (p.s.) 6.51
Sales Per Share 8.34
EBITDA (p.s.) 5.88
Qtrly Earnings Growth -43 %
Operating Cash Flow 244 (M)
Levered Free Cash Flow 208 (M)
Stock Valuations
PE Ratio 24.72
PEG Ratio 4.7
Price to Book value 0
Price to Sales 9.17
Price to Cash Flow 0
Stock Dividends
Dividend 0.92
Forward Dividend 0
Dividend Yield 1.2%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android